Results 41 to 50 of about 282,889 (214)

Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Since the early 2000s, pneumococcal conjugate vaccines (PCVs) have been shown to be effective in the prevention of pneumonia and invasive pneumococcal diseases.
I. Rivero-Calle   +7 more
doaj   +1 more source

Recombinant plants provide a new approach to the production of bacterial polysaccharide for vaccines. [PDF]

open access: yes, 2014
Bacterial polysaccharides have numerous clinical or industrial uses. Recombinant plants could offer the possibility of producing bacterial polysaccharides on a large scale and free of contaminating bacterial toxins and antigens.
G. C. Whitelam (7665758)   +58 more
core   +1 more source

Evaluation of epidemiological and clinical features of patients with pneumococcal and legionella pneumonia

open access: yesBiomedical and Biotechnology Research Journal, 2019
Background: Pneumonia is one of the major causes of morbidity, mortality, and hospitalization. It is developed by a variety of organisms including Streptococcus pneumoniae and Legionella spp.
Tina Rabooki   +4 more
doaj   +1 more source

Pneumococcic Vaccine In Pneumonia [PDF]

open access: yesThe American Journal of the Medical Sciences, 1909
n ...
openaire   +1 more source

Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012.

open access: yesPLoS ONE, 2015
BackgroundStreptococcus pneumoniae is a leading cause of pneumonia worldwide. However, the burden of pneumococcal pneumonia among adults in low- and middle-income countries is not well described.MethodsData from 2008-2012 was analyzed from two ...
Carmen Lucía Contreras   +9 more
doaj   +1 more source

Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children

open access: yes, 2012
BACKGROUND AND AIM OF THE WORK: Since the introduction of the 7-valent vaccine, invasive pneumococcal disease have greatly decreased; however, changes in the distribution of pneumococcal serotypes have recently highlighted the need for vaccines with ...
Valleriani, Claudia   +26 more
core   +2 more sources

Continued control of pneumococcal disease in the UK - the impact of vaccination

open access: yes, 2011
Streptococcus pneumoniae, also known as the pneumococcus, is an important cause of morbidity and mortality in the developed and developing world. Pneumococcal conjugate vaccines were first introduced for routine use in the USA in 2000, although the seven-
Gladstone, R.A.   +11 more
core   +1 more source

A model for predicting bacteremia in patients with community-acquired pneumococcal pneumonia: a retrospective observational study

open access: yesBMC Pulmonary Medicine, 2018
Background Pneumococcal pneumonia causes high morbidity and mortality among adults. This study aimed to identify risk factors for bacteremic pneumococcal pneumonia, and to construct a prediction model for the development of bacteremia in patients with ...
Yasuyoshi Washio   +4 more
doaj   +1 more source

Pneumococcal Pneumonia

open access: yesChest, 2012
Vaccination and antimicrobial therapy remain the cornerstones of the management of pneumococcal pneumonia. Despite significant successes, the capacity of the pneumococcus to evolve in the face of the selective pressure of anticapsular immunity challenges immunization programs.
Dockrell, David H.   +2 more
openaire   +2 more sources

Pneumococcal carriage in sub-Saharan Africa--a systematic review. [PDF]

open access: yes, 2014
BACKGROUND: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV)
Bottomley, Christian   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy